POMMICRO

POMDOCTOR Ltd

HealthcareMedical - Pharmaceuticals
$1.48
$0.00(+4.23%)
52W$0.28
$115.74
Updated Jun 28, 02:00 AM
RSI36
RS Rating1/99
Beta0.73
Volatility271%
F-Score4/9
Mkt Cap$10M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

POMDOCTOR Ltd is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 1), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (271% annualized), which requires wider risk management.

Relative Strength
1
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
0.73
vs S&P 500
DEFENSIVE
52W Position
1%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.61
50 SMA > 100 SMA$4.37
100 SMA > 150 SMA$12.14
150 SMA > 200 SMA$

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.71-13.48%BELOW
50 SMA$3.61-59.01%BELOW
100 SMA$4.37-66.10%BELOW
150 SMA$12.14-87.81%BELOW
200 SMA$

Price Performance

1D+4.2%
1W+5.7%
1M-24.5%
3M-69.5%
6M-76.7%
YTD-74.8%
1Y-98.0%
3Y-72.7%
52-Week Trading Range1% from low
$1.48
52W Low$0.28
52W High$115.74

Technical Indicators

RSI (14)BEARISH
35.9
305070
Setup Score
/10
Base depth: %

Risk Profile

Beta
0.73
52W Vol
271%
ATR
$0.30
Max DD (1Y)
-100%

Volume Analysis

Today
50D Avg
521.8K
Vol Ratio
0.00x
Liquidity
ILLIQUID
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:+16.73%
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR

10 Years:-32.24%
5 Years:-54.09%
3 Years:-72.67%
1 Year:-97.96%

Return on Equity

10Y Avg:
5Y Avg:
3Y Avg:
Last Year:

Key Metrics

Market Cap$10M
Gross Margin13.9%
Net Margin-41.9%
Piotroski F-Score4/9

Frequently Asked Questions

Is POM in an uptrend right now?

POM has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is POM overbought or oversold?

POM's RSI (14) is 36. The stock is in neutral territory, neither overbought nor oversold.

Is POM outperforming the market?

POM has a Relative Strength (RS) Rating of 1 out of 99. POM is currently lagging the broader market.

Where is POM in its 52-week range?

POM is trading at $1.48, which is 1% of its 52-week high ($115.74) and 1% above its 52-week low ($0.28).

How volatile is POM?

POM has a Beta of 0.73 and 52-week volatility of 271%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.